Profil
Charbel Haber is currently the Senior Vice President-Regulatory Affairs at Moderna, Inc. He was previously the VP-Global Safety & Regulatory Sciences at Biogen, Inc. from 2017 to 2020.
Prior to that, he worked at EMD Serono, Inc. as the Head-Regulatory Affairs Immunology & Neurology.
Postes actifs de Charbel Haber
| Sociétés | Poste | Début |
|---|---|---|
| MODERNA, INC. | Conseiller Juridique Général | 21/04/2020 |
Anciens postes connus de Charbel Haber
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/03/2020 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MODERNA, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
